Matson (MATX) news
Recent news
Matson Inc: JP Morgan raises target price to $310 from $270
J.P. Morgan has revised its price target for Matson Inc. (MATX), raising it to $310 from the previous $270, reflecting a positive reassessment of the company’s outlook amid evolving market conditions. The adjustment suggests that analysts at the firm believe the stock is undervalued relative to its…
AInvest Wire · 1d agoTavexia Lifecare - Board approves acquisition of 60% controlling stake in Meyonex Pharmaceuticals
Tavexia Lifecare Limited (TAVX) has announced that its board of directors has approved the acquisition of a 60% controlling stake in Meyonex Pharmaceuticals. The move is expected to strengthen Tavexia’s position in the pharmaceutical sector by expanding its product portfolio and enhancing its…
AInvest Wire · 2d agoLogistic stocks fell in intraday trading after sector-wide M&A activity and freight rate volatility, with CHRW down 3.97%, MATX falling 3.36% and SVRN sliding 4.25%.
AInvest Wire · Oct 6, 2026Stephens raises target price to $260 from $240 for Matson Inc
AInvest Wire · Aug 4, 2026Matson - expects FY 2026 CAPEX $150-$170 mln, vessel construction $400 mln, dry-docking $45 mln
Matson, Inc. (NYSE: MATX) has outlined its capital expenditure plans for fiscal year 2026, with expectations for total capital spending to range between $150 million and $170 million. This includes maintenance and other capital expenditures. The company also anticipates new vessel construction…
AInvest Wire · Aug 3, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.